Etsy (NASDAQ:ETSY) is a niche e-commerce website specializing in handmade and vintage goods. ETSY stock launched its initial public offering (IPO) back in 2015, initiating around $25 per share. Source: Shutterstock ETSY was initially a bust, with shares sliding into the single digits. But the company turned things around starting in 2018. Now the stay-at-home
Up nearly 150% this year, Square (NYSE:SQ) could be due for a pullback at some point soon. Investors should hope that scenario comes to pass because SQ stock is set up for long-term gains. Source: IgorGolovniov / Shutterstock.com The novel coronavirus pandemic is cementing Square’s status as one of the must-own fintech names. That’s impressive
Recent data on Gilead’s (NASDAQ:GILD) treatment for the novel coronavirus, remdesivir, along with multiple indications that demand for the drug is strong, have caused me to continue to be upbeat on GILD stock. Source: Casimiro PT / Shutterstock.com Further, a key supply deal involving remdesivir and an overreaction to negative news about another one of
The novel coronavirus has fundamentally altered the investing landscape. Many sectors that were already struggling, like energy and brick-and-mortar retail, have seen their slow declines turn into abject free fall. Other businesses, such as video gaming and work-from-home software companies, are booming. Many companies that initially plunged are now turning into huge rebound stocks. For
German biotech firm, CureVac (NASDAQ:CVAC), has gained some major heat since making its debut in the public market less than two weeks ago. The company saw its shares nearly tripled in value on the first day of trading and CureVac stock rose from $16 per share to $44. Source: Shutterstock The need for a vaccine
Alibaba (NYSE:BABA) is at an all-time high. After middling around in the early summer, Alibaba stock broke out in early July and it hasn’t looked back. But at the time of this writing the stock is up over 11% since the e-commerce giant reported earnings on August 20. That has some investors wondering if Alibaba
Maryland-based vaccine maker Novavax (NASDAQ:NVAX) has been one of 2020’s high-flying stocks. Closing out 2019 at under $4, NVAX stock hit $178.51 on Aug. 10. That’s a whopping gain of nearly 4,400% in just eight months. Source: Ascannio/Shutterstock.com The reason for that remarkable performance was the novel coronavirus pandemic. More specifically, Novavax’s Covid-19 vaccine efforts.
Investors typically look at gold and other precious metals in times of market turmoil. Naturally, gold has become a safe haven for investors as the novel coronavirus changes the landscape of financial markets. Hence, investors are clamoring to buy gold stocks as gold prices have risen 27% year to date. However, things have not been
The market was a bit wobbly today, but several indices still found a way to hit new all-time highs. With that in mind, let’s look at a few top stock trades for Friday. Top Stock Trades for Tomorrow No. 1: Walmart (WMT) Walmart (NYSE:WMT) caught a major bid on Thursday as reports swirled that it’s
The New York Stock Exchange has won the approval from regulators to allow companies to issue new shares through direct listings, creating a cheaper alternative to the traditional initial public offering. The Securities and Exchange Commission said in an order Wednesday evening that it approved a new type of direct listing where companies can simultaneously
Fans gather at local Ulta Beauty in Houston to greet Kylie Jenner at the launch of her cosmetics line on November 18, 2018 in Houston, Texas. Rick Kern | Getty Images Check out the companies making headlines after the bell: Ulta Beauty — Shares of Ulta Beauty soared 18% in extended trading after the beauty retailer
Peloton Interactive, Inc. (PTON) shares rose about 4% during Thursday’s session after Goldman Sachs reiterated its Buy rating and raised its price target to a Street high of $96.00 per share. Analyst Heath Terry cited channel checks showing net additions for the quarter, suggesting that the quarter could be well in front of consensus expectations.
If you think that things are acting without any order or sense, you need to watch this video. I’ll tell you why stocks sell-off even if earnings are great. And sometimes, stocks have horrible earnings, but it goes to the upside. Let’s see why that is the case. #selloffstock #stockearnings #stocks #greatearnings #stockmarket #topstock Posted
Exxon Mobil (NYSE:XOM) declared another quarterly dividend even though it clearly cannot afford it. Exxon Mobil stock now has a very high dividend yield of 8.5%. It is inching higher as more believe that the company cannot sustain its dividend. Source: Michael Gordon / Shutterstock.com As I pointed out in my previous article, Exxon’s management
When I last weighed in on Chesapeake Energy (OTCMKTS:CHKAQ), I said, “Bankruptcy is in the offing, as the energy firm buckles under far too much debt.” That was back in May 2020, as Chesapeake Energy stock traded at $31 after a 200:1 reverse split. Source: IgorGolovniov / Shutterstock.com But that was a no-brainer observation. With high
CNBC’s Jim Cramer on Thursday praised the Federal Reserve and its chairman, Jerome Powell, for updating their approach to monetary policy to help the U.S. economy recover from the coronavirus pandemic. “Powell is on the side of the bulls,” Cramer said on “Squawk on the Street.” The Fed earlier Thursday said it would be willing to
Protesters block a courthouse entrance in Los Angeles on Aug. 21, 2020. VALERIE MACON | AFP | Getty Images The rich really are getting richer. We know this, but two Federal Reserve economists have recently examined the evidence and concluded the gap is getting even wider. Federal Reserve Board economists Isabel Cairo and Jae Sim
The Fed wants its policies to lift many more boats and go far deeper to get lower income and underemployed Americans to work, before it pulls back from its easy policy stance. Fed Chairman Jerome Powell Thursday announced that the Fed tweaked its inflation policy, indicating it would be willing to allow inflation to run
Unlike every other crisis that America has faced in modern history, the novel coronavirus pandemic affects each of us directly. No one can say that they haven’t felt the impact of this terrible outbreak. Therefore, the upcoming 2020 election could very well be a one-issue race. But don’t adopt the same singular attitude for your
iBio Pharma (NYSEAMERICAN:IBIO) remains behind in the world’s vaccine quest. And just as quickly as it rose, IBIO stock is quickly fading into irrelevance. Source: Shutterstock The company’s FastPharming platform, using plant-based protein production, is unique and interesting. I can see how theoretically it could be used to quickly mass-produce a novel coronavirus vaccine. But